Nervous about the process? We break down what the onboarding experience actually looks like — from first form to first injection — at the top telehealth GLP-1 programs.
Most GLP-1 review content focuses on whether the medication works. Spoiler: it does, when properly dosed and monitored. The more useful question for most patients evaluating programs is: what is the actual experience of getting started? What will they ask me? How long will it take? What could go wrong?
This article answers those questions based on our analysis of patient-reported onboarding experiences across the major telehealth GLP-1 platforms.
Despite differences in branding and platform design, most legitimate telehealth GLP-1 programs follow a similar onboarding sequence:
Every legitimate program starts with a health history questionnaire. This is not bureaucracy for its own sake — it's how a prescriber can safely evaluate your candidacy without an in-person visit. Expect questions about:
Programs that skip this level of intake detail should concern you. The questions exist because a prescriber is supposed to be making a clinical decision based on your actual health status.
Most programs collect payment information before the prescriber review, not after. This is standard practice — they're not charging you until the prescription is issued, but they capture the information upfront. Programs with transparent pricing show the full monthly cost at this stage. If prices appear only after you've entered payment details, that's a transparency problem.
A licensed prescriber — physician, NP, or PA — reviews your intake and determines your eligibility. This can be asynchronous (they review your form and issue a decision without a live call) or synchronous (a brief video or phone consultation). Both can be clinically appropriate depending on your health complexity.
Once prescribed, your medication is compounded and shipped. This is where program quality differences become tangible. Better programs:
First injection experiences vary widely based on starting dose. Programs that start patients at 0.25mg/week of semaglutide or the equivalent tirzepatide starting dose see dramatically lower rates of severe nausea. Programs that start patients too high see the complaints that fill review threads.
Patient reports consistently describe Synergy Rx's intake as thorough but navigable. Approval within 48 hours is the norm for standard cases. Shipping tracking is provided. Dosing instructions are clear. The first-injection experience is well-supported.
SHED's most consistent compliment in process reviews is speed. Patients frequently report same-day or next-day approvals. The platform design is modern and intuitive — less friction than older programs. Dosing guidance is proactive.
Care Bare Rx is specifically praised for pricing transparency throughout onboarding. Patients report that what they saw at intake matched what they paid — a more significant differentiator than it sounds in a market with hidden fees.
Red flag process signs patient reviews consistently flag:
Three questions worth asking any telehealth GLP-1 program before committing:
Programs with confident, specific answers to all three are worth your business. Programs that deflect or provide vague answers are telling you something important.
We've done the vetting. Compare Synergy Rx, SHED, Care Bare Rx, and more on our full provider comparison page.
See All Provider Comparisons →